Nuo Therapeutics Inc (AURX) financials · rev $3.1M
Nuo Therapeutics Inc (AURX) rev $3.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $3.3M | $1.4M |
| Cost of Revenue | $1.1M | $302.8K |
| Gross Profit | $2.2M | $1.1M |
| Operating Income | -$2.5M | -$2.5M |
| Net Income | -$2.5M | -$2.3M |
| EPS (Diluted) | $0.00 | $0.00 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.8M | $1.2M |
| Current Assets | $1.4M | $841.5K |
| Cash & Equivalents | $548.9K | $283.7K |
| Inventory | $213.8K | $150.4K |
| PP&E | $366.3K | $177.0K |
| Total Liabilities | $2.8M | $675.8K |
| Current Liabilities | $1.3M | $578.5K |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | -$956.6K | $513.7K |
| Retained Earnings | -$34.8M | -$32.3M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$865.0K | -$2.2M |
| CapEx | $274.8K | $155.0K |
| Investing Cash Flow | -$274.8K | -$155.0K |
| Financing Cash Flow | $1.4M | $1.7M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $265.2K | -$645.0K |
| Free Cash Flow | -$1.1M | -$2.4M |
FAQ
What is AURX P/E and revenue?
Nuo Therapeutics Inc (AURX) rev $3.1M.
What is AURX revenue?
Nuo Therapeutics Inc last cached revenue is $3.3M (FY2025).
Is AURX profitable?
Nuo Therapeutics Inc last cached net income is -$2.5M.
What are AURX total assets?
Nuo Therapeutics Inc last cached total assets are $1.8M.
What is AURX free cash flow?
Nuo Therapeutics Inc last cached free cash flow is -$1.1M.
Not investment advice. Cached statements, not a live tape.